Study of ATX-01 in Participants With DM1

Clinical trial NCT06300307 · RECRUITING

Trial details

NCT number: NCT06300307
Sponsor: ARTHEx Biotech S.L.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy 1

Start date: 2024-10-15
Primary completion: 2027-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.